Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3911 | Technology based social interactions Wiki | 1.00 |
| drug2588 | No research related technology based social interactions Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D008569 | Memory Disorders NIH | 1.00 |
| D000544 | Alzheimer Disease NIH | 0.35 |
| D060825 | Cognitive Dysfunction NIH | 0.26 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0002354 | Memory impairment HPO | 1.00 |
| HP:0002511 | Alzheimer disease HPO | 0.35 |
| HP:0001268 | Mental deterioration HPO | 0.26 |
Navigate: Correlations HPO
There is one clinical trial.
Integrating ICT in health promotion has been suggested to offer many advantages compared to traditional approaches to promote well-being. Research has shown the positive effects of a body-mind-spirit (BMS) approach in enhancing health and well-being. We will develop and assess a pilot trial involving a holistic BMS approach to promote positive emotion change, emotion regulation and self-awareness through an ICT-supported program in a community setting.
Description: Change assessed by the Subjective Happiness Scale (SHS). The minimum and maximum of SHS are 4 to 24, respectively. A higher score means a better outcome.
Measure: Positive emotion Time: Baseline and one monthDescription: Change assessed by the Perceived Stress Scale (PSS). The minimum and maximum of SHS are 0 to 16, respectively. A higher score means a worse outcome.
Measure: Stress level Time: Baseline and one monthDescription: Change assessed by a one-item Personal Happiness scale. The minimum and maximum of SHS are 0 to 10, respectively. A higher score means a better outcome.
Measure: Personal well-being Time: Baseline and one monthDescription: Change assessed by a 3-item Family well-being scale. The minimum and maximum are 0 to 30, respectively. A higher score means a better outcome.
Measure: Family well-being Time: Baseline and one monthDescription: Change assessed by the Patient Health Questionnaire-4. The minimum and maximum of SHS are 0 to 28, respectively. A higher score means a worse outcome.
Measure: Negative emotion Time: Baseline and one monthDescription: Change assessed by the Insomnia Severity Index (ISI). The minimum and maximum of SHS are 0 to 28, respectively. A higher score means a worse outcome.
Measure: Sleep quality Time: Baseline and one monthDescription: Change assessed by outcome-based questions. A score of each question ranges from 1-5. A higher score a better outcome.
Measure: Knowledge and attitudes towards and practice of the holistic BMS health care approach Time: Baseline and one monthDescription: Assessed by outcome-based questions with categorical choices
Measure: Perceived benefits of the BMS program Time: One monthDescription: Assessed by outcome-based questions with categorical choices
Measure: Sharing of BMS with others Time: One monthAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports